Old Web
English
Sign In
Acemap
>
authorDetail
>
Elizabeth Stoddert
Elizabeth Stoddert
Virginia Commonwealth University
Bortezomib
Immunology
Medicine
Neutropenia
Chronic lymphocytic leukemia
3
Papers
20
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Phase 1 Study of Bortezomib and Romidepsin in Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Indolent B-Cell Lymphoma, Peripheral T-Cell Lymphoma, or Cutaneous T-Cell Lymphoma: Updated Results
2014
Blood
Beata Holkova
Maciej Kmieciak
Prithviraj Bose
Shuo Ma
Amy Kimball
Mary Beth Tombes
Ellen Shrader
Wen Wan
Caryn Weir-Wiggins
Elizabeth Stoddert
Amanda Singh
April Dean
Sarah Conine
Heidi Sankala
John D. Roberts
Thomas C. Shea
Steven Grant
Show All
Source
Cite
Save
Citations (8)
Phase I Study of Bortezomib and Romidepsin in Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Indolent B-Cell Lymphoma, or Peripheral T-Cell Lymphoma
2012
Blood
Beata Holkova
Thomas C. Shea
Prithviraj Bose
Mary Beth Tombes
Ellen Shrader
Wen Wan
Caryn Weir-Wiggins
Elizabeth Stoddert
Heidi Sankala
Maciej Kmieciak
John D. Roberts
Steven Grant
Show All
Source
Cite
Save
Citations (5)
Phase I Trial of Belinostat and Bortezomib in Patients with Relapsed or Refractory Acute Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia in Blast Crisis - One Year Update
2011
Blood
Beata Holkova
Prithviraj Bose
Mary Beth Tombes
Ellen Shrader
Wen Wan
Caryn Weir-Wiggins
Elizabeth Stoddert
Heidi Sankala
Maciej Kmieciak
John D. Roberts
Guillermo Garcia-Manero
Steven Grant
Show All
Source
Cite
Save
Citations (7)
1